$10M
Qualified
maximum offering price, as qualified
—
Reported Sold
no 1-K or 1-Z states a sold amount
3
Filings
across 2 offerings
Equity Classes
| Type | Class | Outstanding | CUSIP | Publicly Traded |
|---|---|---|---|---|
| common | N/A | 252,504,841 | 02300U205 | OTCPinksheets |
| preferred | Series A | 250 | — | — |
| preferred | Series B | 249,999 | — | — |
| preferred | Series C | 99 | — | — |
| preferred | Series D | 0 | — | — |
| preferred | Series E | 1,140 | — | — |
| preferred | Series H | 455 | — | — |
Service Providers
| Role | Provider |
|---|---|
| blue sky | N/A |
| legal | Eilers Law Group, P.A. |
Offerings
| File Number | Filings | First Filed | Last Filed | Price/Security | Securities Offered | Aggregate Offering | Estimated Net | Withdrawn |
|---|---|---|---|---|---|---|---|---|
| 024-11084 | 2 | 2019-09-27 | 2020-01-09 | $0.10 | 50,000,000 | $5M | $5M | — |
| 024-11138 | 1 | 2020-01-09 | 2020-01-09 | $0.10 | 50,000,000 | $5M | $5M | 2020-01-10 |
The statements and reported figures behind Amarantus Bioscience Holdings, Inc.
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
External link: SEC Filings